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Background: Palliative Care (PC) aims to improve the quality of life for patients with
cancer and their families and its benefits have been demonstrated by several studies.
The objective of this systematic review is to assess the integration of PC in the content
of  guidelines/pathways of adult cancer patients in Europe.
Methods: We included studies of adult patients with cancer published from 01/01/1995
and 31/12/2013 in Europe in six languages. We searched nine electronic databases,
hand-searched six journals and also performed citation tracking. Studies were ranked
using Emanuel's Integrated Palliative Care (IPC) criteria, a tool containing eleven
domains to assess PC content in guidelines. Two reviewers screened the results and
narrative synthesis has been employed.
Results: We identified a total of 28,277 potentially relevant articles from which 637
were eligible for full-text screening. The final review included 60 guidelines and 14
pathways.  Eighty percent (80%) of the guidelines/ pathways emphasize a holistic
approach and 66% focus on PC interventions aimed at reducing suffering. Fifty seven
percent (57%) did not discuss referral criteria for PC. Of all studies, five fulfilled at least
10/11 IPC criteria. Differences existed with regard to the referral criteria for
bereavement care and the continuous adjustment of goals of care.
Conclusion: Overall, most of the identified guidelines/pathways highlighted the
importance of the holistic approach of IPC. The studies that were found to fulfil at least
10/11 Emanuel's IPC criteria could serve as benchmarks of IPC.
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Letter to the Editor 
 
Dear Editor of BMC Palliative Care,  
First, we thank you for your comments and suggestions. We have taken into account all the 
comments and have modified the manuscript accordingly. In what follows, we describe in 
detail our response to each of the comments/concerns that you raised. Moreover, in order to 
render the tracking of changes easier, we have highlighted with yellow all the corrections in 
the manuscript. 
Editor’s comment 1: “The authors have added references 12 and 13 based on feedback from 
Reviewer 1.  These references relate more to Page 3, Lines 55-61 then they do to Page 3, 
Lines 63-68.  Therefore, we recommend changes references 12 and 13 to references 5 and 6 
and associating them in Line 61.  Only a few other reference numbers will need to change as a 
result of this”. 
Response: We thank the Editor for his suggestion. We have followed his recommendation 
and we replaced references 12 and 13 with references 5 and 6 and the citations are 
accordingly changed in the text. 
 
Editor’s comment 2: “The authors edited the word "extant" elsewhere in the document.  We 
recommend changing this word (Page 3, Line 68) to "available" to increase 
comprehensibility”. 
Response: We have followed The Editor’s recommendation and we replaced the word 
“extant” with the word “available”. 
 
Editor’s comment 3: “Attention is drawn to reference 14 which the abstract describes as a 
study reporting on the use of patient established prioritization of symptoms to improve 
symptom control at EOL.  The text discusses that cancer patients get suboptimal EOL care.  If 
reference 14 is the best source for this assertion, then OK to leave as is.  If this was not the 
reference intended for this assertion, then please replace with the best reference available to 
defend this assertion”. 
Cover Letter
Response: We agree with the Editor’s suggestion, therefore, we have replaced the previous 
reference 14 with the new reference “Foley KM, Gelband H. Improving Palliative Care for 
Cancer. Washington, DC: Institute of Medicine and National Research Council; 2001”. 
 
Editor’s comment 4: “Page 4, Line 73:  consider changing "reside" to "die" as references 15-
17 speak more to preferences regarding place of death and not place of residence, which seem 
like different topics to the Reviewer”. 
Response: We agree with the Editor. We have replaced the word “reside” with the word “die” 
which is deemed more appropriate for the context of the two cited papers.  
 
Editor’s comment 5: The Reviewer looked at the www.insup-c.edu website and was able to 
find the tables.  Given Tables 1 and 2 are included in this manuscript, authors could consider 
removing the reference to the website.  If the Tables are included on the website in a format 
that is not conducive to being included in this manuscript, then assure the weblink listed is a 
direct link to the page with the Tables. 
Response: We agree with the Editor’s comment and since we have included the tables in the 
manuscript, we removed the weblink throughout the text.  
 
Editor’s comment 6: “Page 9, Line 211:  consider removing "or patients with other life-
limiting illnesses" as the title of the manuscript defines adult cancer patients as the population 
of interest in this review”. 
Response: We have followed the Editor’s recommendation and the phrase “or patients with 







To what degree is palliative care integrated in guidelines and pathways for adult cancer 2 
patients in Europe: A systematic literature review. 3 
 4 
Abstract 5 
Background: Palliative Care (PC) aims to improve the quality of life for patients with cancer 6 
and their families and its benefits have been demonstrated by several studies. The objective 7 
of this systematic review is to assess the integration of PC in the content of  8 
guidelines/pathways of adult cancer patients in Europe. 9 
 10 
Methods: We included studies of adult patients with cancer published from 01/01/1995 and 11 
31/12/2013 in Europe in six languages. We searched nine electronic databases, hand-12 
searched six journals and also performed citation tracking. Studies were ranked using 13 
Emanuel’s Integrated Palliative Care (IPC) criteria, a tool containing eleven domains to assess 14 
PC content in guidelines. Two reviewers screened the results and narrative synthesis has 15 
been employed. 16 
 17 
Results: We identified a total of 28,277 potentially relevant articles from which 637 were 18 
eligible for full-text screening. The final review included 60 guidelines and 14 pathways.  19 
Eighty percent (80%) of the guidelines/ pathways emphasize a holistic approach and 66% 20 
focus on PC interventions aimed at reducing suffering. Fifty seven percent (57%) did not 21 
discuss referral criteria for PC. Of all studies, five fulfilled at least 10/11 IPC criteria. 22 
Differences existed with regard to the referral criteria for bereavement care and the 23 
continuous adjustment of goals of care. 24 
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Conclusion: Overall, most of the identified guidelines/pathways highlighted the importance 26 
of the holistic approach of IPC. The studies that were found to fulfil at least 10/11 Emanuel’s 27 
IPC criteria could serve as benchmarks of IPC. 28 
 29 
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According to EUROSTAT [1], cancer constitutes the second most common cause of death in 50 
the European Union, which amounts for 29% and 23% of deaths for men and women, 51 
respectively. Moreover, these numbers are expected to increase as a result of the ageing of 52 
the population.  53 
 54 
Palliative Care (PC) amounts to optimizing the quality of life for patients and their families 55 
facing problems associated with cancer, and other life-threatening disease more generally. 56 
In this framework, focus is placed on i) the alleviation of symptoms, ii) the up-to-date 57 
communication of treatment goals and iii) the support for both patients and their families 58 
throughout the course of the illness trajectory. Importantly, the effectiveness of palliative 59 
care on the improvement of the quality of life of patients with advanced cancer has been 60 
corroborated by an ever-growing bulk of research evidence [2-6].  61 
 62 
Several health-care authorities and medical associations including the World Health 63 
Organization (WHO), the European Society of Medical Oncology (ESMO), the American 64 
Society of Clinical Oncology (ASCO), The National Comprehensive Cancer Network (NCCN), 65 
The European Association for Palliative Care (EAPC) and Institute for Clinical Systems 66 
Improvement (ICSI) recommend the (early) integration of PC in the illness trajectory [2, 7-67 
13].  However, available studies report that, at the end of life, patients with cancer usually 68 
receive suboptimal care[14], i.e. integration of PC remains limited. A critical examination of 69 
the status quo in Europe reveals that current European health-care delivery for patients with 70 
cancer is suboptimal both from the quality-of-care and from the financial perspective. In 71 




































































list of which includes: i) patients unable to die at their place of preference [15-17], ii) large 73 
discrepancies in treatment trajectories and (non)treatment strategies in those with 74 
advanced cancer, indicating limited consensus on optimal treatment pathways [18-19] and 75 
iii) considerable risks for overburdening of informal caregivers, translating into an imbalance 76 
in care networks surrounding the patient [20-23].  77 
 78 
Central to the successful development and implementation of integrated PC strategies are 79 
the concepts of guidelines and pathways. Guidelines are systematically developed 80 
statements to assist practitioners and patient decisions about appropriate health care for 81 
specific clinical circumstances. They can be national, international or local. As such, they are 82 
often used as a means to reduce variations in treatments within health-care systems, to 83 
develop hospital-tailored protocols, to educate students, to assist insurers etc., [24-26]. On 84 
the other hand, a care pathway is defined as a complex intervention for the mutual decision 85 
making and organisation of care processes for a well-defined group of patients during a well-86 
defined period. A pathway may use guidelines to provide clinical care. 87 
 88 
The objective of the present study is to identify existing guidelines and pathways of 89 
integrated PC for people with cancer in the European Union and evaluate their completeness 90 
of content regarding their level of PC integration by conducting a systematic review of the 91 






































































Despite the fact that there is a growing awareness of integrated palliative care (IPC) a 95 
unanimously agreed definition for it does not exist. For the scopes of this study, the InSup-C 96 
experts developed a consensus based definition that reads: 97 
“Integrated palliative care involves bringing together administrative, organisational, clinical 98 
and service aspects in order to realise continuity of care between all actors involved in the 99 
care network of patients receiving palliative care. It aims to achieve quality of life and a well-100 
supported dying process for the patient and the family in collaboration with all the care 101 
givers (paid and unpaid)”. 102 
Search strategy 103 
The following databases were searched electronically: The Cochrane Central Register of 104 
Controlled Trials (CENTRAL), PubMed, EMBASE, CINAHL, AMED, British Nursing index (BNI), 105 
Web of Science, National Guidelines Clearinghouse and NHS Evidence. The search in the 106 
databases was performed using judiciously chosen keywords and search terms as well as 107 
their permutations/combinations. The basic search terms and keywords that were used in 108 
the electronic databases are presented in Box 1. 109 
Box 1: Search terms used for the database search. 110 
 111 
Additionally, the following journals were hand-searched: BMJ Supportive & Palliative care, 112 
European Journal of Palliative Care, Journal of Pain and Symptom Management, Palliative 113 
Medicine, Medicina Paliativa and the references from the included guidelines/pathways.  114 
The grey literature search consisted of two parts. For the first part, named individuals within 115 
national scientific medical organizations, were contacted with the aim of gathering 116 
information on guidelines and pathways. Examples of professional organizations included 117 




































































grey literature search involving an electronic search in Google. For this search, the search 119 
strategy was translated in the languages of the authors participating in this study.  120 
 121 
Selection criteria 122 
As mentioned in the introduction, this study is performed in the context of the InSup-C 123 
research project. For this reason, in compliance with the project’s objectives this review is 124 
geographically limited in Europe. Further, the following inclusion criteria were used: 125 
1. Guidelines and pathways for adult patients. 126 
2. Guidelines and pathways for cancer (latest possible versions). 127 
3. European guidelines and pathways. 128 
4. Guidelines and pathways published from 01-01-1995 to 31-12-2013 (with the start 129 
date based on the publication of the Calman-Hine report which constitutes the first 130 
national cancer plan in Europe [27]). 131 
5. Languages: English, French, German, Dutch, Hungarian and Spanish (the languages of 132 
the authors) 133 
To distinguish between studies focusing on PC from those focusing on IPC, a sixth eligibility 134 
criterion is needed. In the present study, we measure the completeness of the IPC content of 135 
the guidelines/pathways via a tool based on Emanuel’s IPC criteria. This is a template 136 
designed by the American Hospice Foundation Guidelines Committee to provide a practical 137 
approach for guideline writers and others to integrate PC into disease management and care 138 
services whenever it is relevant [28]. These criteria are described in Box 2. For the needs of 139 
the present study, and following a consensus in the InSup-C consortium, a 140 




































































criteria. Therefore, guidelines/pathways that fulfilled at most one criterion were labelled as 142 
non-eligible. 143 
 144 
It is important to note that, to the best of our knowledge, Emanuel’s criteria constitute the 145 
only tool that evaluates the content of the guidelines/pathways regarding the level of PC 146 
integration. Consequently, even though this tool has not been empirically validated, it has 147 
been chosen as the best choice. 148 
Box 2. Integrated Palliative Care (IPC) Criteria. 149 
 150 
Selection procedure  151 
In the first phase, the first two authors (KVB and NS) screened all the English search results 152 
based on their titles and their abstract. Non English texts were screened and translated by 153 
two native speaker researchers. Then the full texts of the guidelines/pathways selected by 154 
both authors were sourced and they were reviewed based on the aforementioned 155 
inclusion/exclusion criteria. Discrepancies were resolved by consensus or they were 156 
extensively discussed in consecutive project meetings. 157 
 158 
Data extraction 159 
Data were extracted from guidelines/pathways meeting the inclusion criteria using a data 160 
extraction form. This form was based on the extraction form described in Hawker et. al 161 
(2002), but it was adjusted accordingly to the purposes of our study after consensus in the 162 
project meetings [29]. For each included paper, data extraction was carried out by the two 163 




































































the non-English ones. Upon the completion of the process, the two reviewers cross-checked 165 
their results and reached consensus in case of discrepancies.  166 
 167 
Evidence quality assessment  168 
In order to assess the quality of the evidence of the guideline/pathways, we employed the 169 
following methodology. Guidelines/ pathways that were based on both systematic reviews 170 
and consensus methods (e.g. nominal group techniques, Delphi rounds, expert 171 
consultations) or those developed by following the NICE protocol [30] were considered high 172 
quality evidence; guidelines/pathways based on systematic review only or based on other 173 
types of well referenced evidence were considered medium quality whereas those based on 174 
consensus methods only were considered low quality. Finally, guidelines/pathways whose 175 
basis was unclear (e.g. apparently evidence based but failing to clarify how this was 176 
obtained) were considered of very low quality. This quality assessment guide was agreed 177 
upon during consensus between the authors.  178 
 179 
Data synthesis 180 
The included studies are characterized by a substantial heterogeneity. For this reason, a 181 
narrative synthesis has been considered appropriate and results have tabulated in easily 182 




We identified a total of 28,277 potentially relevant documents/records, of which 24,794 187 




































































through consultation with experts and national health organizations. An additional 3,021 189 
relevant papers were identified from the hand-searched journals, citation tracking and the 190 
grey literature, of which 2,905 were not eligible for full text screening. Full-text review was 191 
performed on the remaining 521 articles from the electronic database search and 116 192 
articles from the other sources mentioned above. The final review included 74 papers of 193 
which 60 were guidelines [31-90] and 14 pathways [91-104]. The characteristics of these 194 
studies can be found in Tables 1 and 2. A flow diagram of the selection procedure and results 195 
(using the PRISMA tool [105]) is shown in Figure 1. 196 
 197 
 Figure 1: Flow diagram of study selection procedure. 198 
 199 
Of the 60 guidelines included in the final review, 28 guidelines originated from the UK, seven 200 
from Germany, three from Belgium, 5 from Spain, 15 from the Netherlands and two from 201 
Hungary. Additionally, four pathways originated from the UK and Spain, three from the 202 
Netherlands and one from Belgium, Germany and Hungary. Twenty eight guidelines and 5 203 
pathways can be considered as cancer specific (e.g. breast cancer guidelines, lung cancer 204 
guidelines, etc.). Four guidelines deal with general oncology, eleven guidelines and 3 205 
pathways with the dying phase for patients with cancer and chronic disease, sixteen 206 
guidelines and 6 pathways with PC in general and one guideline is about general health care. 207 
It is important to note here, that the guidelines/pathways focused on general PC and general 208 
health care are not irrelevant to the scopes of this systematic review because they are 209 
concerned with patients with cancer.  In this respect, these guidelines/ pathways fulfil the 210 
inclusion criterion on the type of the disease and as such they are included in the study. 211 




































































Looking at the results of the quality assessment of the evidence, we have to stress that the 213 
assessment employed in the present systematic review does not assess the quality of the 214 
implementation of the included guidelines/ pathways. Rather, it provides a means of 215 
evaluating the principles upon which they have been developed. Very low quality 216 
guidelines/pathways corresponded to only 11% of the total number. Guidelines/ pathways 217 
with low quality were 27%. Only a handful of studies (7%) were categorised as medium 218 
quality. Finally, the majority of the included guidelines/pathways (55%) were classified as of 219 
high quality evidence. 220 
 221 
The assessment of the palliative care content of the guidelines/pathways via the IPC criteria 222 
revealed the following information. Nearly 80% of the studies placed particular emphasis on 223 
the holistic approach, namely the assessment of the patient’s physical, psychological, social 224 
and spiritual issues, although only half of these recommendations (37%) specified the exact 225 
timing on when these holistic assessments should take place. Of all guidelines/pathways, 226 
47% reported on the timing at which palliative care should be integrated. An additional 66% 227 
of the guidelines/pathways focused on palliative care interventions aimed at reducing 228 
suffering. Interestingly, 75% of the included guidelines/pathways referred to both an 229 
inpatient and an outpatient PC setting, as opposed to 16% and 8% that referred solely to an 230 
inpatient and an outpatient PC setting, respectively. Moreover, 55% of the 231 
guidelines/pathways explicitly put emphasis on discussion of illness limitations and prognosis 232 






































































Just less than half of the included guidelines/pathways paid attention to aspects of advance 236 
care planning (46%) and grief and bereavement care (40%). Furthermore recommendations 237 
for continuous goal adjustment (38%), recommendations of care during the last hours of life 238 
(47%) and recommendations for the involvement of a palliative care team (58%), were 239 
mixed.  240 
 241 
Guidelines and pathways that achieved a high score using the IPC criteria were judged to 242 
comprehensively address the core components of IPC. Two guidelines and one pathway 243 
scored 11/11 whereas two others scored 10/11. These five studies were also ranked as of 244 
high quality evidence which means that they were developed based on both consensus and 245 
literature review. Of interest is that these five studies are not specific oncology guidelines, 246 
but PC or End of Life Care guidance. The guidelines/pathways that scored 10 or 11/11 are 247 
presented and analysed in Table 3 and the strategies that they propose can be summarised 248 
as follows: 249 
1) Discussion of illness limitations and prognosis: The guidelines/pathways agree that 250 
this can be realized through open and honest communication with patient and 251 
family, based on their needs and preferences, and enabling shared decision making. 252 
One pathway also suggests the employment of the surprise question or the Palliative 253 
Performance Scale can be used as triggers for initiating such discussions.  254 
2) Holistic assessment: There is a unanimous consensus on the utilization of a 255 
combined physical, psychological, social and spiritual assessment. 256 
3) Timing of the holistic assessments: Assessment should take place early in the disease 257 
trajectory. Further, it is recommended that holistic assessment  should occur “at any 258 




































































for patient’s social participation. Also, its realization should vary depending on 260 
changes in the disease or on the appearance of new symptoms and based on 261 
application of e.g. a ‘distress thermometer’. 262 
4) Exact timing of introducing PC: Three strategies are identified: i) the use of the 263 
surprise question, ii) the evaluation of the patient’s and the family’s needs, iii) illness 264 
stage – disease/cancer related prognostic indicators (e.g. like the indicators 265 
mentioned in the Gold Standards Framework). 266 
5) Patient’s goals assessments: All the guidelines/pathways agree that this assessment 267 
should be based on the continuous communication between the patient and the PC 268 
specialists to identify patient goals. 269 
6) Continuous goal adjustment: It is suggested that PC specialists regularly consult the 270 
patient and adjust goals accordingly. 271 
7) Suffering reduction: The guidelines/pathways elaborate on the use of appropriate 272 
medication and strategies aimed in reducing both physical and psychological 273 
suffering. 274 
8) Advance care planning (ACP): Decision making should be based on patient’s wishes 275 
and preferences. One pathway proposes the identification of the ACP via the use of 276 
three models (covenant model, contract model or DNR code). 277 
9) Involvement of PC team: All of the guidelines/pathways strongly recommend the 278 
involvement or formation of a multidisciplinary PC team (consisting of physicians, 279 
nurses and other health professionals, psychologists, mental health counsellors, 280 




































































10) Care during the last hours of living: The following steps are recommended: 282 
identification of the dying phase, communication, support based on patients and 283 
family’s needs and wishes and symptom control. 284 
11) Grief and bereavement care: The main proposed strategy involves the immediate 285 
and ongoing bereavement, emotional and spiritual support appropriate to the 286 
family’s needs and preferences. 287 
 288 
The point at which PC should be introduced in the disease trajectory and which referral 289 
criteria should apply was addressed in less than half of the total of the included guidelines 290 
and pathways. This could be seen to have a significant impact on the benefits of PC if not 291 
introduced to patients in a timely manner. In view of this, it is surprising that 59% (n=43) of 292 
all the included guidelines/pathways did not discuss (adequately or at all) referral criteria.  293 
 294 
The distribution of the guidelines/pathways that explicitly mentioned the referral criteria 295 
shows that 8% recommended that the referral criterion should be for terminally ill people 296 
without specifying the exact timing. Further, 7% reported that the referral criteria should be 297 
located in the last six months. Also, 4% of the guidelines reported as a referral criterion the 298 
surprise question ("Would I be surprised if this patient died in the next year?") whereas 8% 299 
the reference of fulfilment of specific prognostic criteria mentioned in the Gold Standards 300 
Framework or Stadium IVB [106-107]. The presence of metastatic disease was considered as 301 
a referral criterion by 15% of all the studies whilst 13% suggested the application of the 302 
guidelines as soon as the diagnosis of cancer has been made. Finally, one guideline 303 
recommended that the referral criteria should be determined upon a discussion with the 304 






































































The results of the systematic review identified 74 guidelines/pathways fulfilling our inclusion 308 
criteria. Geographically, the majority of the included studies originated from the UK. 309 
Moreover, only five of them scored at least 10/11 of the IPC criteria. 310 
 311 
Although there is significant improvement in cancer treatment, still half of all patients with 312 
cancer will eventually die of their disease and in one third this will happen within 6 months 313 
of diagnosis [108]. Currently, European and American oncology organisations such as ASCO, 314 
ESMO, and NCCN, recommend the early integration of PC for patients with cancer [2, 109]. 315 
These recommendations have been evidenced by studies that corroborate the positive 316 
relationship between early integration of PC and improvements in the quality of life of the 317 
patients, leading to better patient and caregiver outcomes, improvement of symptoms and 318 
patient satisfaction, with reduced caregiver burden, and reduced use of futile interventions 319 
[3, 12, 110-112]. Despite this evidence, cancer patients tend to be referred to PC late in their 320 
disease trajectory [12]. The implementation of PC integration is highly dependent on staff 321 
perception (misconception) of PC that often gets mistaken for terminal care [113].  322 
 323 
The guidelines and pathways made a number of recommendations about how to introduce 324 
pc into oncology care. These included recommendations on how PC can be implemented 325 
earlier in oncology care are education of providers and public about the importance of PC 326 
and to coordinate PC efforts through strengthening affiliations and/or developing new 327 
partnerships [114]. One way to educate clinicians would be the integration of  PC in disease 328 





































































According to our findings, most of the included guidelines/ pathways recommend the need 331 
of a holistic PC approach e.g. a whole patient assessment. Additionally, it is also recognised 332 
that the reduction of suffering by implementing specific PC interventions e.g. use of opioids 333 
or analgesics, should be among the primary goals of integrated PC. This is in agreement with 334 
empirical evidence that illustrate the advantages of both the holistic approach and the focus 335 
on the reduction of suffering [115-116]. 336 
 337 
A noteworthy outcome has been the general shortage in the guidelines of information on 338 
the specification on when PC should be initiated (PC referral criteria). Moreover, even 339 
among those guidelines/pathways that comment on the timing of referral, there is great 340 
variability e.g. surprise question, life expectancy less than 6 months, presence of metastatic 341 
disease, etc. We consider this important because clear referral criteria enable the initiation 342 
of the guideline/ pathway. Consequently, this is correlated with the overall efficiency of a 343 
guideline/ pathway. The notable absence of references to the referral criteria and the strong 344 
disagreement between those that mention them deserve further exploration.  345 
 346 
More generally, there is a growing recognition that the PC should be considered around the 347 
time of diagnosis [117]. However, available research hints that that these recommendations 348 
alone are not sufficient for the practical determination of the referral criteria [118-119]. 349 
With regard to cancer, a robust definition of the referral criteria is quite cumbersome and 350 
detailed and systematic methods need further development [120]. NCCN states that all 351 
patients should be screened for PC needs at their initial visit, at appropriate intervals and as 352 




































































care and palliative care should be considered early in the course of illness for any patient 354 
with metastatic cancer and/or high symptom burden [12].  In Germany, Gaertner et al 355 
developed diagnosis specific guidelines for 19 malignancies to identify a disease- specific 356 
point in each disease trajectory to initiate palliative care [11]. In view of the above, we 357 
conclude that the establishment of PC referral criteria in guidelines for cancer patients 358 
remains an elusive and contentious topic which demands further attention. 359 
 360 
Interestingly, guidelines/ pathways give less attention to advance care planning, grief and 361 
bereavement support for the family members, and continuity of care. This outcome is 362 
surprising because the significance of these aspects has been highlighted by several studies 363 
[9,121-122]. Oncologists have to give their patients clear and consistent prognostic 364 
information as this will help facilitate discussions about patients’ end of life care 365 
preferences. Fears among oncologists that early PC consultation will frighten their patients 366 
are unfounded and the opposite has been proven [123]. Oncologists must ensure that 367 
advance care plans are in place as early as possible in the disease trajectory [8]. 368 
Bereavement support is gaining attention in the oncology field, with the NCCN guidelines 369 
being the first guideline that sees after-death care for the family as an essential part of the 370 
continuum of cancer care [8]. 371 
 372 
With the exception of the referral criteria, the holistic approach and the reduction of 373 
suffering, the compliance with Emmanuel’s IPC criteria of the included guidelines/ pathways 374 
varies widely. In turn, this implies that the fulfilment of integrated PC criteria is generally not 375 
taken into consideration when designing cancer guidelines/ pathways. Previous studies 376 




































































limiting disease already revealed that top-selling textbooks and guidelines on chronic, life-378 
limiting illnesses offer little information on caring for patients at the end of life [124]. Our 379 
findings reveal that five of the guidelines/pathways fulfilled at least 10 out of 11 IPC criteria 380 
(in fact three fulfilled all 11 criteria).  381 
 382 
A closer look at the content of these guidelines has shown that they offer similar 383 
recommendations on IPC (table 3). This has a three-fold importance. First it affirms that 384 
these 5 guidelines can serve as a benchmark for PC integration in cancer guidelines. Second, 385 
it hints that for all the guidelines/ pathways that scored moderately or low, there is a 386 
considerable room for improvement. Finally, it supports the appropriateness of using 387 
Emanuel’s tool for the evaluation of the PC content of guideline data. 388 
 389 
To conclude, it can be inferred that, even though small discrepancies do exist, the strategies 390 
proposed by the guidelines/pathways that scored the highest have strong content similarity. 391 
In turn, this suggests that there is a common conception concerning the incorporation of 392 
integrated PC into the framework for guidelines/pathways. 393 
 394 
Finally, it is important to reiterate that we should differentiate between the completeness of 395 
guidelines/pathways content and its performance following its clinical implementation. 396 
Although a correlation between the two is quite likely to exist, a high score with respect to 397 
Emmanuel’s criteria cannot be considered to necessarily speculate on the efficacy of the 398 
guidelines/ pathways in the clinical context. Future research could explore the clinical utility 399 





































































Study limitations 402 
As is the case with any study that aspires to conduct a systematic literature review, a major 403 
limitation stems from the choice of the search strategy. We started with a broad search not 404 
only focussing on cancer but also on chronic disease. The results of the latter will be the 405 
subject of a subsequent article. More specifically, the search of the electronic databases 406 
returned a large amount of articles, many of which originated outside Europe. 407 
 408 
In general, there is a lack of standardised definitions regarding integrated PC [8]. For the 409 
needs of this study, we furnished our own functional definition. However, our results might 410 
differ if a different definition had been employed. 411 
 412 
An additional limitation stems from the confinement to guidelines/pathways published in 413 
Dutch, English, French, German, Hungarian and Spanish. Hence, one may not exclude the 414 
possibility that more guidelines and pathways exist in other languages spoken in the EU.   415 
 416 
As mentioned above, the evaluation of the content of the guidelines/pathways used 417 
Emmanuel’s criteria. The authors of this study, in collaboration with all the InSup-C project 418 
partners, decided to use this tool on the basis of its apparent completeness. Therefore, one 419 
may not exclude the possibility that a different assessment tool would lead to a different 420 
score of the guidelines/ pathways and thus a different hierarchy. Additionally, we only 421 
performed a limited analysis of the content of recommendations of IPC based on the most 422 





































































Finally, the fact that we included only guidelines that included only 2 or more of the 11 425 
Emanuel’s IPC criteria might have skewed the results favouring a more positive view of 426 
integration of PC in oncology care in Europe. 427 
 428 
Conclusions 429 
Five studies were found to fulfil at least 10/11 of the IPC criteria for completeness on IPC. 430 
These guidelines/pathways proposed very similar strategies for the realization of these 431 
criteria and were based on high levels of evidence. Consequently, they could serve as 432 
benchmarks of how PC can be integrated in cancer guidelines. As such, they also can provide 433 
a base to further investigate what constitutes integrated PC in cancer.  434 
 435 
Our systematic review has revealed the importance of a holistic approach and interventions 436 
aimed at reducing suffering by deploying an integrated palliative care approach. 437 
Additionally, our results illustrate that there is disagreement on the appropriate referral 438 
criteria for IPC which remains a contentious and challenging topic in terms of the integration 439 
of PC in cancer care.  440 
 441 
As mentioned above, the included guidelines/pathways do not embody aspects of 442 
implementation. Therefore, even though the theoretical framework of these guidelines/ 443 
pathways conforms reasonably well to the state of the art in IPC, their applicability in 444 
practice needs to be further investigated.  445 
 446 
Overall, our findings have identified both the strengths and the weaknesses of the available 447 




































































palliative care. Consequently, we anticipate that our findings may  inform physicians and 449 
policy makers as a framework in their efforts to improve the integration of PC in the  care of 450 
people with cancer. 451 
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Box 1: Search terms used for the database search. 
 
(hospices OR supportive care OR supportive care* OR end of life care* OR 
palliative* OR palliative care [MeSH Terms] OR hospice* OR terminal care* OR 
coordinated care* OR integrated care* OR transmural care* OR progressive patient 
care*) AND ("end stage disease" OR end stage disease* OR dying OR death [MeSH 
Terms] OR Chronic disease [MeSH Terms] OR Chronic disease* OR terminally ill* OR 
terminally ill [MeSH Terms] OR cancer) AND (care pathway* OR care pathway OR 
pathway* OR patient transfer* OR patient transfer OR patient care team* OR 
managed care program* OR continuity of patient care OR patient care management 
OR patient care plan* OR patient care planning OR illness trajectory OR "advance 
care planning" OR advance care planning OR delivery of health care OR models of 
care OR model of care OR model organizational OR models organizational OR 
organizational model* OR guideline*) NOT ((birth) OR child) OR pediatrics)) NOT 





Table Click here to download Table Box 1. Cancer.docx 
Box 2. Integrated Palliative Care (IPC) Criteria. 
 
1. Discussion of illness limitations and prognosis. 
2. Recommendations for conducting a whole patient assessment including the 
patient’s physical, social, psychological, and spiritual issues, their family and 
community setting. 
3. Recommendations for when to make these assessments (e.g.  At baseline and 
periodically thereafter). 
4. Recommendations on when palliative care should be integrated. 
5. Assessment of the patient’s goals for care. 
6. Continuous goal adjustment as the illness and the person’s disease progresses. 
7. Palliative care interventions to reduce suffering as needed. 
8. Advance care planning. 
9. Recommendation of involving a palliative care team (interdisciplinary team, 
palliative care consultation or other palliative care services). 
10. Recommendations on care during the last hours of living. 
11. Recommendations on grief and bereavement care. 
 
Table Click here to download Table Box 2. Cancer.docx 
  
Table 1. Characteristics of included Cancer Guidelines. 
 
Cancer Guidelines 
Title/ Country/ Year Setting Emanuel’s criteria (EMC) Quality of 
Evidence 
 
Interdisciplinary guideline of quality for 
early detection, diagnosis and 
treatment of different stages of 
prostate cancer /Germany/ 2011. [31] 
inpatient/ 
outpatient 
7 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Timing of PC introduction, Patient’s 
goals, Suffering reduction, ACP, Involvement of PC team. 
High 
Practice guideline for palliative care/ 
Germany/ 2009. [32] 
outpatient 9 EMC: Holistic assessments, Timing of PC introduction, 
Patient’s goals, Continuous goal adjustment, Suffering 
reduction, ACP, Involvement of PC team, Last hours of living 
care, Grief and bereavement care.  
Low 
Interdisciplinary guidelines for the 
diagnosis, treatment and follow-up of 
breast cancer/ Germany/ 2012. [33] 
inpatient/ 
outpatient 
9 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Timing of holistic assessments,  Timing 
of PC introduction, Patient’s goals, Continuous goal 
adjustment, Suffering reduction, Involvement of PC team, 
Last hours of living care. 
High 
Guideline: Prevention, Diagnosis, 
Therapy, and Follow-up of Lung Cancer. 
(Germany, 2010) [34] 
inpatient/ 
outpatient 
9 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Timing of PC introduction, Patient’s 
goals, Continuous goal adjustment, Suffering reduction, ACP, 
Involvement of PC team, Last hours of living care. 
High 
Malignant melanoma S3-guideline: 
Diagnosis, treatment and aftercare of 
melanoma. (Germany, 2013) [35] 
inpatient/ 
outpatient 
7 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Timing of holistic assessments,  Timing 
of PC introduction, Suffering reduction, ACP, Involvement of 
PC team. 
High 
Cancer pain. (Germany, 2007) [36] inpatient/ 
outpatient 
3 EMC: Holistic assessments, Timing of holistic assessments, 
Continuous goal adjustment. 
High 
Directive of the Federal Joint 
Committee on the Regulation of 
specialized outpatient palliative care. 
(Germany, 2007). [37] 
outpatient  6 EMC: Holistic assessments, Patient’s goals, Suffering 
reduction, ACP, Involvement of PC team, Last hours of living 
care. 
Very low 
National Practice Guideline pancreatic 
cancer. (Belgium, 2009) [38] 
inpatient 3 EMC: Holistic assessments, Timing of PC introduction, 
Involvement of PC team. 
High 
Small cell and non- small cell lung 
cancer: diagnosis, treatment and 
follow-up. (Belgium, 2013) [39] 
inpatient 2 EMC: Patient’s goals, ACP. High 
National Practice Guideline of 
oesophageal and stomach cancer – 
UPDATE. (Belgium, 2012) [40] 
inpatient 4 EMC: Holistic assessments, Timing of PC introduction, 
Suffering reduction, Involvement of PC team. 
High 
Palliative Care Unit: Standards and 
Recommendations. (Spain, 2009) [41] 
inpatient/ 
outpatient 
8 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Timing of PC introduction, Patient’s 
goals, Suffering reduction, ACP, Involvement of PC team, 
Grief and bereavement care. 
High 
Clinical Practice Guidelines on Palliative 
Care. (Spain, 2008) [42] 
inpatient/ 
outpatient 
10 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Timing of PC introduction, Patient’s 
goals, Continuous goal adjustment, Suffering reduction, ACP, 
Involvement of PC team, Last hours of living care, Grief and 
bereavement care. 
High 
Palliative Care Guideline. (Spain, no 
date available) [43] 
inpatient/ 
outpatient 
3 EMC: Involvement of PC team, Last hours of living care, 
Grief and bereavement care. 
Very low 
Palliative Care Guideline in the 




5 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Timing of PC introduction, Suffering 
reduction, Last hours of living care.  
Very low 
Clinical recommendations guideline: 
colorectal cancer. (Spain, 2006). [45] 
  4 EMC: Holistic assessments, Timing of PC introduction, 
Continuous goal adjustment, Grief and bereavement care. 
High 
Guideline Care in the dying phase. (The 
Netherlands, 2010) [46] 
inpatient/ 
outpatient 
8 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Timing of PC introduction, Patient’s 
goals, Suffering reduction, ACP, Last hours of living care, 
Grief and bereavement care. 
Low 
Table Click here to download Table Table 1. Characteristics of
included Cancer Guidelines..docx
  
Guideline Leptomeningeal metastases. 
(The Netherlands, 2010) [47] 
inpatient/ 
outpatient 
4 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Timing of PC introduction, Suffering 
reduction. 
High 
Guideline Oncologic Rehabilitation. 
(The Netherlands, 2011) [48] 
inpatient/ 
outpatient 
6 EMC: Holistic assessments, Timing of holistic assessments,  
Timing of PC introduction, Patient’s goals, Continuous goal 
adjustment, Suffering reduction. 
Medium 




5 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Timing of holistic assessments,  
Patient’s goals, Suffering reduction. 
High 
Guideline Melanoma. (The 
Netherlands, 2013) [50] 
inpatient/ 
outpatient 
3 EMC: Discussion of illness limitations and prognosis, 
Timing of PC introduction, Suffering reduction. 
High 
Guideline Oesophagus carcinoma. (The 
Netherlands, 2010) [51] 
inpatient/ 
outpatient 
8 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Timing of holistic assessments,  Timing 
of PC introduction, Patient’s goals, Continuous goal 
adjustment, Suffering reduction, ACP.  
High 
Guideline Pancreas carcinoma. (The 
Netherlands, 2011) [52] 
inpatient/ 
outpatient 
3 EMC: Discussion of illness limitations and prognosis, 
Patient’s goals, Suffering reduction. 
High 
Guideline cervix carcinoma. (The 
Netherlands, 2012) [53] 
inpatient/ 
outpatient 
4 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Suffering reduction, ACP, Involvement 
of PC team. 
High 
Guideline Endometrial carcinoma. (The 
Netherlands, 2011) [54] 
inpatient/ 
outpatient 
2 EMC: Discussion of illness limitations and prognosis, 
Involvement of PC team. 
High 
Guideline Sarcoma carcino-sarcoma 
uterus. (The Netherlands, 2010) [55] 
inpatient/ 
outpatient 
2 EMC: Holistic assessments, Involvement of PC team. Low 
Guideline Hypo-pharynx carcinoma. 
(The Netherlands, 2010) [56] 
inpatient/ 
outpatient 
5 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Timing of holistic assessments,  Timing 
of PC introduction, Suffering reduction. 
High 
Guideline Larynx carcinoma. (The 
Netherlands, 2010) [57] 
inpatient/ 
outpatient 
5 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Timing of holistic assessments, Timing 
of PC introduction, Suffering reduction. 
High 
Guideline Mouth and oropharynx 




5 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Timing of holistic assessments, Timing 
of PC introduction, Suffering reduction. 
High 
Guideline Breast cancer. (The 
Netherlands, no date available) [59] 
inpatient/ 
outpatient 
4 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Timing of holistic assessments, 
Suffering reduction. 
High 
Guideline Prostate carcinoma. (The 
Netherlands, 2007) [60] 
inpatient/ 
outpatient 
3 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Patient’s goals. 
High 
Professional Guideline (Directive) of 
the Hungarian Public Healthcare. 
(Hungary, 2013) [61] 
inpatient 10 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Timing of holistic assessments,  
Patient’s goals, Continuous goal adjustment, Suffering 
reduction, ACP, Involvement of PC team, Last hours of living 
care, Grief and bereavement care. 
Medium 
Recommendations for the 
development of an integrative and 
complex palliative care in Hungary. 
(Hungary, 2013) [62] 
inpatient/ 
outpatient 
8 EMC: Discussion of illness limitations and prognosis, 
Timing of holistic assessments,  Timing of PC introduction, 
Patient’s goals, Continuous goal adjustment, Suffering 
reduction, ACP, Grief and bereavement care. 
High 
Guidance on Cancer Services: 
Improving Supportive and Palliative 




9 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Timing of holistic assessments,  
Patient’s goals, Suffering reduction, ACP, Involvement of PC 
team, Last hours of living care, Grief and bereavement care. 
High 
Making good care better: 
National practice statements for 
general palliative care in adult care 
homes in Scotland. (UK-Scotland, 2006) 
[64] 
outpatient 8 EMC: Holistic assessments, Patient’s goals, Continuous 
goal adjustment, Suffering reduction, ACP, Involvement of 
PC team, Last hours of living care, Grief and bereavement 
care. 
Low 
The diagnosis and treatment of lung 
Cancer-updated. (UK, 2011) [65] 
inpatient 4 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Timing of holistic assessments, 
Suffering reduction. 
High 
Head and Neck Cancer: 
Multidisciplinary Management 
Guidelines. (UK, 2011) [66] 
inpatient/ 
outpatient 
7 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Patient’s goals, Continuous goal 
adjustment, Suffering reduction, Involvement of PC team, 
High 
  
Last hours of living care. 
Guidelines for supportive care in 
multiple myeloma 2011. (UK, 2011) 
[67] 
inpatient 4 EMC: Holistic assessments, Timing of holistic assessments, 
Suffering reduction, ACP, Last hours of living care.  
High 
The NICE Guidance on Supportive and 
Palliative Care  Implications for 
Oncology Teams. (UK, 2004) [68] 
inpatient 5 EMC: Holistic assessments, Patient’s goals, Suffering 
reduction, Involvement of PC team, Grief and bereavement 
care. 
High 
Metastatic malignant disease of 
unknown primary origin. Diagnosis and 
management of metastatic malignant 
disease of unknown primary origin. 
(UK, 2010) [69] 
inpatient 3 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Continuous goal adjustment. 
High 
Palliative and End of Life Care 
Indicators. (UK-Scotland, 2013) [70] 
inpatient/ 
outpatient 
3 EMC: Discussion of illness limitations and prognosis, 
Patient’s goals, ACP. 
Low 
Core competencies in palliative care: 
an EAPC White Paper on palliative care 
education. Parts 1 & 2. (UK, 2013) [71] 
inpatient/ 
outpatient 
8 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Timing of holistic assessments, 
Patient’s goals, Continuous goal adjustment, ACP, 
Involvement of PC team, Grief and bereavement care. 
Low 
Dying well at home: the case for 




7 EMC: Holistic assessments, Patient’s goals, Suffering 
reduction, ACP, Involvement of PC team, Last hours of living 
care, Grief and bereavement care. 
Low 
RCGP commissioning guidance in end 
of life care : guidance for GPs, clinical 




7 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Patient’s goals, Continuous goal 
adjustment, Involvement of PC team, Last hours of living 
care, Grief and bereavement care. 
Low 
Optimising the role and value of the 
interdisciplinary team: providing 




9 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Timing of holistic assessments,  
Patient’s goals, Continuous goal adjustment, ACP, 
Involvement of PC team, Last hours of living care, Grief and 
bereavement care. 
Low 
Strategy for adult palliative and end of 
life care services. (UK, 2013) [75] 
inpatient/ 
outpatient 
8 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Patient’s goals, Continuous goal 
adjustment, Suffering reduction, Involvement of PC team, 
Last hours of living care, Grief and bereavement care. 
Low 
End of Life Care Strategy: Fourth 
Annual Report. (UK, 2012) [76] 
inpatient/ 
outpatient 
3 EMC: ACP, Last hours of living care, Grief and bereavement 
care. 
High 
Matters of life and death: helping 
people to live well until they die. 
General practice guidance for 
implementing the RCGP/RCN end of life 
care patient charter. (UK, 2012) [77] 
inpatient/ 
outpatient 
11 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Timing of holistic assessments,  Timing 
of PC introduction, Patient’s goals, Continuous goal 
adjustment, Suffering reduction, ACP, Involvement of PC 
team, Last hours of living care, Grief and bereavement care. 
High 
End of life care for adults in the 
Emergency Department. (UK, 2012) 
[78] 
inpatient 4 EMC: Discussion of illness limitations and prognosis, 
Timing of PC introduction, ACP, Involvement of PC team. 
High 




11 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Timing of holistic assessments,  Timing 
of PC introduction, Patient’s goals, Continuous goal 
adjustment, Suffering reduction, ACP, Involvement of PC 
team, Last hours of living care, Grief and bereavement care. 
High 
Commissioning guidance for specialist 
palliative care : helping to deliver 




6 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Timing of PC introduction, Patient’s 
goals, ACP, Involvement of PC team. 
Low 
Commissioning person centred end of 
life care. (UK, 2012) [81] 
inpatient/ 
outpatient 
2 EMC: ACP, Involvement of PC team. Low 
Quality standard for end of life care for 
adults. (UK, 2011) [82] 
inpatient/ 
outpatient 
8 EMC: Holistic assessments, Timing of holistic assessments, 
Patient’s goals, Continuous goal adjustment, ACP, 
Involvement of PC team, Last hours of living care, Grief and 
bereavement care. 
High 
Advanced breast cancer: Diagnosis and 
treatment. (UK, 2009) [83] 
inpatient/ 
outpatient 
3 EMC: Holistic assessments, Timing of holistic assessments, 
Involvement of PC team.  
High 
Review of palliative care services in inpatient/ 4 EMC: Holistic assessments, Patient’s goals, ACP, High 
  
Scotland. (UK-Scotland, 2008) [84] outpatient Involvement of PC team. 
Living and Dying Well: A national action 
plan for palliative and end of life care in 
Scotland. (UK-Scotland, 2008) [85] 
inpatient/ 
outpatient 
8 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Timing of holistic assessments,  Timing 
of PC introduction, Patient’s goals, Suffering reduction, ACP, 
Involvement of PC team. 
Low 
Metastatic spinal cord compression: 
Diagnosis and management of patients 
at risk of or with metastatic spinal cord 
compression. (UK, 2008) [86] 
inpatient/ 
outpatient 
2 EMC: Holistic assessments, Involvement of PC team. High 
End of life care. (UK, 2008) [87] inpatient/ 
outpatient 
5 EMC: Holistic assessments, Patient’s goals, ACP, Last hours 
of living care, Grief and bereavement care. 
Medium 
National Care Standards: Hospice Care. 
(UK, 2005) [88] 
inpatient/ 
outpatient 
2 EMC: Last hours of living care, Grief and bereavement 
care. 
Low 
Clinical Standards: Specialist palliative 
care. (UK, 2002) [89]  
inpatient 7 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Patient’s goals, Continuous goal 
adjustment, ACP, Involvement of PC team, Grief and 
bereavement care. 
Low 
Improving outcomes in gynaecological 
cancer: The Manual. (UK, 1999) [90] 
inpatient/ 
outpatient 




Table 2. Characteristics of included Cancer Pathways. 
 
Cancer Pathways 
Title/ Country/ Year Setting Emanuel’s criteria (EMC) Quality of 
Evidence 
 
Palliative Medicine: Essays - Reports - 
Discussion Posts - Comments: Liverpool 
Care Pathway Practical assistance. 
(Germany, 2008) [91] 
inpatient 7 EMC:  Holistic assessments, Timing of PC introduction, 
Patient’s goals, Continuous goal adjustment, Suffering 
reduction, ACP, Last hours of living care. 
Very low 
Practice and opportunities of the 
Hungarian hospice care provided at 
home. (Hungary, 2013) [92] 
Inpatient/ 
outpatient 
8 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Timing of holistic assessments,  Timing 
of PC introduction, Patient’s goals, Continuous goal 
adjustment, Suffering reduction, Last hours of living care. 
Low 
Palliative care pathway in General 
Practice. (Belgium, 2012) [93] 
outpatient 11 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Timing of holistic assessments,  Timing 
of PC introduction, Patient’s goals, Continuous goal 
adjustment, Suffering reduction, ACP, Involvement of PC 
team, Last hours of living care, Grief and bereavement care. 
High 
Integrated Oncological Pathways:  




5 EMC: Discussion of illness limitations and prognosis, 
Holistic assessments, Suffering reduction, Involvement of PC 
team, Last hours of living care. 
Medium 
Integrated Oncological Pathways:  colon-




4 EMC: Timing of PC introduction, Suffering reduction, 
Involvement of PC team, Last hours of living care. 
High 
Flow chart glioblastoma. (The 
Nederlands, 2012) [96] 
inpatient/ 
outpatient 
4 EMC: Timing of holistic assessments,  Timing of PC 
introduction, Involvement of PC team, Last hours of living 
care. 
Very Low 
Manual for the management of patients 
in palliative care in outpatient  
ER. (Spain, 2011) [97] 
outpatient 4 EMC: Discussion of illness limitations and prognosis, 
Timing of PC introduction, Suffering reduction, Last hours of 
living care. 
Low 
Home care program in primary care. 
(Spain, 2004) [98] 
outpatient 6 EMC: Holistic assessments, Timing of PC introduction, 
Suffering reduction, Involvement of PC team, Last hours of 
living care, Grief and bereavement care. 
Very low 
Integrated care process of Palliative Care. 
(Spain, 2007) [99] 
inpatient/ 
outpatient 
7 EMC: Holistic assessments, Timing of PC introduction, 
Suffering reduction, ACP, Involvement of PC team, Last 
hours of living care, Grief and bereavement care. 
High 
Palliative care in the oncologic patient. 
Documents for integrated care processes 




4 EMC: Holistic assessments, Suffering reduction, 
Involvement of PC team, Grief and bereavement care. 
Very low 
Care pathway for the last days of life. 
(UK-Wales, 2004) [101] 
inpatient 8 EMC: Holistic assessments, Patient’s goals, Continuous 
goal adjustment, Suffering reduction, ACP, Involvement of 
PC team, Last hours of living care, Grief and bereavement 
care. 
Very low 
The route to success in end of life care: 




8 EMC: Holistic assessments, Patient’s goals, Continuous 
goal adjustment, Suffering reduction, ACP, Involvement of 
PC team, Last hours of living care, Grief and bereavement 
care. 
Low 
Quality in melanoma care: a best practice 
pathway. (UK, 2012) [103] 
inpatient/ 
outpatient 
4 EMC: Holistic assessments, Patient’s goals, ACP, 
Involvement of PC team. 
High 
Derbyshire End of Life Care Guidance: a 
pathway for supporting people in the last 
year of life. (UK, 2010) [104] 
inpatient/ 
outpatient 
8 EMC: Holistic assessments, Timing of holistic assessments, 
Patient’s goals, Suffering reduction, ACP, Involvement of PC 






Table Click here to download Table Table 2. Characteristics of
included Cancer Pathways..docx
Table 3. Top 5 ICP guidelines and pathways 















CMG42 End of life 






should be based 
on patients’ and 
their family‘s 
needs rather than 
the expected 
survival time. 
Information about  
the illness, decision 
making, and 
discussions about 
death should be 






(PPS) to define 
prognosis or when 
to enter PC 
services. 











in account always 
the patient’s and 


















according to the 
nature of the 
illness. 
Recommendations 
on how to assess 
patients  and how 
to deal with  their 
physical, emotional, 
psychological, 












social, emotional  
and spiritual 
support. Use of the 
Gold Standard 
Framework   (GSF). 
Timing for holistic 
assessments 
Not included assessment takes 





changes in the 
disease trajectory. 
Whenever the 
patient is seen by 
the GP or nurse 
using the ‘distress 
thermometer’.  
At any time of 
day or night for 
physical and 
psychological 
support and as 
long as possible 
for  the social 
participation. 
At any time of day 
or night for physical 
and psychological 
support and as long 
as possible for  the 
social participation. 
Timing for PC 
introduction 
Interventions 
based on the 
Not included Surprise Question: 
“Would you be 
Ask the Surprise 
Question “Would 
Timely access to 
generalist and 
Table Click here to download Table Table 3. Top 5 ICP guidelines and pathways.docx 
patients &their 





surprised if your 
patient were to die 
in the next months, 
weeks, days?”.   
you be surprised 
if the patient 
were to die in the 
next months, 
weeks or 
days?”.    
specialist PC 
services on the 








through the life 
goals and 
personal values. 
Patient’s goals for 
care should be 
brought to light. 
At the time of the 
holistic assessment, 
patients goals need 
to be assessed too. 
Regular review of 
patients’ and 




expression of the 
end-of-life patients 
and their needs. 
Continuous goal 
adjustment. 







Patients have the 
right for modifying 
the plan based 
according to their 
needs. 
Interventions 
should be adapted 
to patient’s goals. 
 Whenever there 
are changes in the 
disease trajectory 
patients goals need 
to be reassessed. 
Discussions with 
patients and their 
carers  about  
their future 
needs.  This 
should be done as 
often as it feels 
that is needed. 
Patients and carers 
should be offered  
holistic 
assessments in 
response to their 
changing needs and 
preferences. 
Suffering reduction Evaluation of the 
pain, instructions 
and involvement 
of patient in  
the use of 
analgesics and 
opioids 
depending of the 
pain stage and 
features. 
Medical aspect of 








Based on an 
overview of needs 
of PC patients 
(study done by the 
Federal Knowledge 
Center), several 






needs  at any 





End of life patients 
should have their 
physical and 
psychological needs 
met at any time of 
day or night, 






wishes and goals. 
Previous 
guidelines, wishes 
of the patient 
saved in his 
Patients have the 




treatments, & the 
ACP can be done 
through 3 models 
(Covenant model, 
contract model or 
DNR code) and 
there are guidelines 
Help the patients 
identify the 
choices that they 
may face, assist 






decisions to refuse 
treatment and 
clinical records, 
legal and the 
nearest in charge 
relatives should 
be considered. 
process of making a 
living will 
for urgent and non-
urgent ACP. 
and ensure that 
















provide basic PC 
should be 
promoted; PC at 
any level should 
be provided 
preferably, by a 
multi-disciplinary 
team. 
Implemented by a 
multi-disciplinary 







If prognosis of 
<12m, a 
multidisciplinary 









provide care over 
a 24 hour period 
for people 
approaching the 
end of life. 
Specialist 
multidisciplinary PC 
team should be 
responsive to 
emergency need 
and able to admit 
people approaching 
the end of life at 
any time 
Recommendations 
on care during the 








holistic approach.  
Symptoms and 
signs of death,  
reducing 
medication, 
nutrition, and fluid 
intake during the 
last hours of life. 
Contains a separate 
section on how to 






the dying phase 
(use of Patient 
Charter). Support 
for patient and 




across all relevant 
settings  at any 












according to the 
nature of the 
grief, with 
professionals 
trained to deal 



















support for carer 





spiritual support as 
appropriate to the 
needs and 
preferences of the 
with these issues. carer/ family. 
 
 































Records identified through 
database searching  
(n = 28,277) 
Records after duplicates removed   (n =26,256) 
Records excluded  by 
title/abstract             
(n =24,794) 
Records included by title/ abstract  (n =1,462 ) 
Additional records identified 
through grey literature and citation 
tracking (n=3,021) 
Full-text articles 
excluded (n =825) 
Full-text screened records assessed 
for eligibility (n =637) 
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